Abstract
The risk assessment for gamma-cyhalothrin in light of confirmatory data requested following approval in accordance with Article 6(1) of Directive 91/414/EEC and Article 6(f) of Regulation (EC) No 1107/2009 concluded that the long-term risk to wild mammals from the proposed representative uses of gamma-cyhalothrin was not fully addressed. Following further considerations during the decision-making process, the European Commission asked EFSA to update the risk assessment for wild mammals and consider a restriction to the proposed good agricultural practice (GAP). The outcome of the updated peer review of the risk assessment for wild mammals is presented.